Skip to content

LARIMAR THERAPEUTICS, INC.

LRMR

CIK 0001374690

← back to feed
Revenue (TTM)
$0
Q1 May 2026
Net Income (TTM)
−$132.79M
−105.5% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.72
−57.1% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$89.23M
Q1 May 2026
Cash
$177.91M
Q1 May 2026
Total Debt
$14.55M
Q1 May 2026
Shares Outstanding
103.88M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings